US6410697B1
(en)
*
|
1979-04-20 |
2002-06-25 |
Schering Corporation |
Process for purifying human leukocyte interferon
|
FI77877C
(fi)
*
|
1979-04-20 |
1989-05-10 |
Technobiotic Ltd |
Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
|
US6835557B1
(en)
|
1980-01-08 |
2004-12-28 |
Biogen, Inc. |
DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
|
US4530901A
(en)
*
|
1980-01-08 |
1985-07-23 |
Biogen N.V. |
Recombinant DNA molecules and their use in producing human interferon-like polypeptides
|
IN156128B
(ja)
|
1980-04-03 |
1985-05-18 |
Biogen Nv |
|
CH651308A5
(de)
*
|
1980-07-01 |
1985-09-13 |
Hoffmann La Roche |
Interferone und deren herstellung.
|
US6610830B1
(en)
|
1980-07-01 |
2003-08-26 |
Hoffman-La Roche Inc. |
Microbial production of mature human leukocyte interferons
|
NZ198445A
(en)
*
|
1980-09-25 |
1984-05-31 |
Genentech Inc |
Production of human fibroblast interferon by recombinant dna technology
|
EP0062971B1
(en)
*
|
1981-03-27 |
1990-03-07 |
Imperial Chemical Industries Plc |
Genetically modified microorganisms
|
IL65475A0
(en)
*
|
1981-04-17 |
1982-07-30 |
Meloy Lab |
Production of immune interferon and its mrna
|
EP0085693A1
(en)
*
|
1981-08-14 |
1983-08-17 |
A/S Alfred Benzon |
Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies
|
US4801685A
(en)
*
|
1981-08-14 |
1989-01-31 |
Hoffmann-La Roche Inc. |
Microbial production of mature human leukocyte interferon K and L
|
US4810645A
(en)
*
|
1981-08-14 |
1989-03-07 |
Hoffmann-La Roche Inc. |
Microbial production of mature human leukocyte interferon K and L
|
US4672108A
(en)
*
|
1981-12-07 |
1987-06-09 |
Hoffmann-La Roche Inc. |
Crystalline human leukocyte interferon
|
EP0082481B2
(en)
*
|
1981-12-23 |
1990-09-12 |
Schering Corporation |
Stabilised alpha-interferon formulations and their preparation
|
US5098703A
(en)
*
|
1982-01-15 |
1992-03-24 |
Cetus Corporation |
Interferon-alpha 76
|
US4975276A
(en)
*
|
1982-01-15 |
1990-12-04 |
Cetus Corporation |
Interferon-alpha 54
|
US4973479A
(en)
*
|
1982-01-15 |
1990-11-27 |
Cetus Corporation |
Interferon-α61
|
ZA83768B
(en)
*
|
1982-03-01 |
1983-10-26 |
Hoffmann La Roche |
Homogeneous human immune interferon and process therefor
|
US5827694A
(en)
*
|
1982-03-08 |
1998-10-27 |
Genentech, Inc. |
DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
|
US6432677B1
(en)
|
1982-03-08 |
2002-08-13 |
Genentech, Inc. |
Non-human animal interferons
|
US5831023A
(en)
*
|
1982-11-01 |
1998-11-03 |
Genentech, Inc. |
Recombinant animal interferon polypeptides
|
US4534906A
(en)
*
|
1982-11-01 |
1985-08-13 |
Genentech, Inc. |
Removal of impurities from human leukocyte interferon preparations
|
US4432895A
(en)
*
|
1982-11-24 |
1984-02-21 |
Hoffmann-La Roche Inc. |
Monomeric interferons
|
US4820515A
(en)
*
|
1982-12-13 |
1989-04-11 |
Texas A&M University System |
Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
|
JPS59137417A
(ja)
*
|
1983-01-28 |
1984-08-07 |
Morinaga Milk Ind Co Ltd |
人尿由来コロニ−形成刺激因子及びカリクレインの製造法
|
IL67896A
(en)
*
|
1983-02-13 |
1987-03-31 |
Yeda Res & Dev |
Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
|
US4599306A
(en)
*
|
1983-04-15 |
1986-07-08 |
Amgen |
Monoclonal antibodies which specifically bind to human immune interferon
|
US4723000A
(en)
*
|
1983-07-05 |
1988-02-02 |
Biospectrum, Inc. |
Human interferon gamma and interleukin-2
|
US4710377A
(en)
*
|
1983-08-19 |
1987-12-01 |
American Cyanamid Company |
Antigens and monoclonal antibodies reactive against sporozoites of Eimeria spp.
|
US4675383A
(en)
*
|
1983-11-15 |
1987-06-23 |
The Salk Institute For Biological Studies |
Purification of T-cell growth factor
|
US4568488A
(en)
*
|
1984-01-11 |
1986-02-04 |
Lee Huang Sylvia |
Reverse immunoaffinity chromatography purification method
|
US4499014A
(en)
*
|
1984-02-07 |
1985-02-12 |
Interferon Sciences, Inc. |
Method for purifying gamma-interferon
|
AU594014B2
(en)
*
|
1984-03-21 |
1990-03-01 |
Research Corporation Technologies, Inc. |
Recombinant DNA molecules
|
US4569790A
(en)
*
|
1984-03-28 |
1986-02-11 |
Cetus Corporation |
Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
|
IL71555A
(en)
*
|
1984-04-15 |
1992-06-21 |
State Of Israel Israel Inst Fo |
Bovine interferon
|
US6133433A
(en)
*
|
1984-07-27 |
2000-10-17 |
City Of Hope |
Method for detection and prevention of human cytomegalovirus infection
|
US6242567B1
(en)
|
1984-07-27 |
2001-06-05 |
City Of Hope |
Method for detection and prevention of human cytomegalovirus infection
|
UA29377C2
(uk)
*
|
1984-09-19 |
2000-11-15 |
Новартіс Аг |
Спосіб отримання білка з активністю колонієстимулювального фактора гранулоцитів та макрофагів(gm-csf) приматів
|
US5322837A
(en)
*
|
1985-01-11 |
1994-06-21 |
Genetics Institute, Inc. |
Homogeneous erythropoietin compositions and methods of using same
|
US4677195A
(en)
*
|
1985-01-11 |
1987-06-30 |
Genetics Institute, Inc. |
Method for the purification of erythropoietin and erythropoietin compositions
|
US5792450A
(en)
*
|
1985-02-05 |
1998-08-11 |
Chiron Corporation |
Purified human CSF-1
|
US5532341A
(en)
*
|
1985-03-28 |
1996-07-02 |
Sloan-Kettering Institute For Cancer Research |
Human pluripotent hematopoietic colony stimulating factor
|
IL79176A
(en)
*
|
1985-06-20 |
1992-06-21 |
Kirin Amgen Inc |
Process for the recovery of erythropoietin from a fluid
|
US4667016A
(en)
*
|
1985-06-20 |
1987-05-19 |
Kirin-Amgen, Inc. |
Erythropoietin purification
|
NZ212523A
(en)
*
|
1985-06-24 |
1989-01-06 |
Univ Massey |
Mobile phase for purification of proteins by high performance liquid chromatography
|
GB8522336D0
(en)
*
|
1985-09-09 |
1985-10-16 |
Biogen Nv |
Composition for treatment of allergies
|
US4894439A
(en)
*
|
1986-05-22 |
1990-01-16 |
Cetus Corporation |
N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes
|
US4677197A
(en)
*
|
1985-10-30 |
1987-06-30 |
Cetus Corporation |
Purification method for tumor necrosis factor
|
US5427780A
(en)
*
|
1985-10-30 |
1995-06-27 |
Biogen, Inc. |
Composition comprising Mullerian inhibiting substance-like polypeptides
|
US4770781A
(en)
*
|
1986-03-03 |
1988-09-13 |
Merck & Co., Inc. |
Purification of human interleukin-1 species
|
US5030559A
(en)
*
|
1986-04-01 |
1991-07-09 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the identification of metastatic human tumors
|
US4935372A
(en)
*
|
1986-05-20 |
1990-06-19 |
Dana Farber Cancer Institute |
Art nucleotide segments, vectors, cell lines methods of preparation and use
|
US5028422A
(en)
*
|
1986-05-27 |
1991-07-02 |
Schering Corporation |
Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
|
US4894440A
(en)
*
|
1986-09-17 |
1990-01-16 |
Massachusetts Institute Of Technology |
Method of isolating megakaryocyte stimulatory factor
|
IL84170A0
(en)
*
|
1986-10-17 |
1988-03-31 |
Interferon Sciences Inc |
Method for detecting interferon
|
US4851220A
(en)
*
|
1986-11-26 |
1989-07-25 |
Schering Corporation |
Stable oleaginous gel
|
US4894330A
(en)
*
|
1986-12-23 |
1990-01-16 |
Cetus Corporation |
Purification of recombinant beta-interferon incorporating RP-HPLC
|
US5190751A
(en)
*
|
1987-01-20 |
1993-03-02 |
Schering Corporation |
Treatment of certain leukemias with a combination of gamma interferon and alpha interferon
|
US4853218A
(en)
*
|
1987-02-24 |
1989-08-01 |
Schering Corporation |
Zinc-protamine-alpha interferon complex
|
US5034513A
(en)
*
|
1987-05-27 |
1991-07-23 |
The United States Of America As Represented By The Secretary Of Agriculture |
Avian interleukin-2
|
US4871538A
(en)
*
|
1987-07-13 |
1989-10-03 |
Schering Corporation |
Insoluble copper-alpha interferon complex
|
ES2053712T3
(es)
*
|
1987-10-21 |
1994-08-01 |
Akzo Nv |
Un antigeno proteico reactivo y fragmentos del mismo.
|
US5559212A
(en)
*
|
1988-04-06 |
1996-09-24 |
Alfacell Corporation |
Frog embryo and egg-derived tumor cell anti-proliferation protein
|
US5179198A
(en)
*
|
1988-07-11 |
1993-01-12 |
Hidechika Okada |
Glycoprotein and gene coding therefor
|
US5256410A
(en)
*
|
1988-12-01 |
1993-10-26 |
Schering Corporation |
Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
|
US5661126A
(en)
*
|
1989-01-19 |
1997-08-26 |
The General Hospital Corporation |
Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression
|
WO1990009442A1
(en)
*
|
1989-02-08 |
1990-08-23 |
Uab Research Foundation |
Antiproliferation factor
|
US6221675B1
(en)
|
1989-04-21 |
2001-04-24 |
Amgen, Inc. |
TNF receptors, TNF binding proteins and DNAs coding for them
|
EP0393438B1
(de)
*
|
1989-04-21 |
2005-02-16 |
Amgen Inc. |
TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
|
US7264944B1
(en)
|
1989-04-21 |
2007-09-04 |
Amgen Inc. |
TNF receptors, TNF binding proteins and DNAs coding for them
|
US5766939A
(en)
*
|
1989-05-05 |
1998-06-16 |
Baylor College Of Medicine |
Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
|
US6100054A
(en)
*
|
1989-05-05 |
2000-08-08 |
Baylor College Of Medicine |
Production for recombinant lactoferrin and lactoferrin polypeptides using DNA sequences in various organisms
|
US5571691A
(en)
*
|
1989-05-05 |
1996-11-05 |
Baylor College Of Medicine |
Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
|
IL94183A
(en)
|
1989-05-05 |
2003-09-17 |
Baylor College Medicine |
cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
|
US5849881A
(en)
*
|
1989-05-05 |
1998-12-15 |
Baylor College Medicine |
Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
|
US5216128A
(en)
*
|
1989-06-01 |
1993-06-01 |
Yeda Research And Development Co., Ltd. |
IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it
|
US6143866A
(en)
*
|
1989-07-18 |
2000-11-07 |
Amgen, Inc. |
Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
|
IL95031A
(en)
|
1989-07-18 |
2007-03-08 |
Amgen Inc |
A method of producing a recombinant human necrotic factor absorber
|
US6552170B1
(en)
|
1990-04-06 |
2003-04-22 |
Amgen Inc. |
PEGylation reagents and compounds formed therewith
|
GB9013016D0
(en)
*
|
1990-06-11 |
1990-08-01 |
Mars Uk Ltd |
Compounds
|
JP3230091B2
(ja)
*
|
1990-06-25 |
2001-11-19 |
ウェルファイド株式会社 |
ヒト血清アルブミンの着色抑制方法
|
KR0184598B1
(ko)
*
|
1990-07-02 |
1999-05-01 |
프 레드릭 에이. 랭길 |
이입인자 및 사용방법
|
KR930701601A
(ko)
*
|
1990-07-10 |
1993-06-12 |
디이터 라우디엔, 루돌프 호프만 |
O-글리코실화 ifn-알파
|
JP3015969B2
(ja)
*
|
1990-11-30 |
2000-03-06 |
ダイナボット株式会社 |
扁平上皮癌関連抗原蛋白質及び該蛋白質をコードするdna
|
DE4113949A1
(de)
*
|
1991-04-29 |
1992-11-05 |
Behringwerke Ag |
Schizosaccharomyces spezifische polypeptide
|
AU674306B2
(en)
*
|
1992-02-10 |
1996-12-19 |
Interferon Sciences Inc. |
Improved alpha interferon composition and method for its production from human peripheral blood leukocytes
|
US5676942A
(en)
*
|
1992-02-10 |
1997-10-14 |
Interferon Sciences, Inc. |
Composition containing human alpha interferon species proteins and method for use thereof
|
US5521287A
(en)
*
|
1992-05-20 |
1996-05-28 |
The Green Cross Corporation |
Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
|
US5440018A
(en)
*
|
1992-05-20 |
1995-08-08 |
The Green Cross Corporation |
Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
|
US5434249A
(en)
*
|
1992-05-27 |
1995-07-18 |
Viragen Inc. |
Method for modulating specific activity of inteferon alpha
|
JPH08500242A
(ja)
*
|
1992-06-24 |
1996-01-16 |
メルク エンド カンパニー インコーポレーテッド |
インターロイキン1β前駆体の転換酵素をコードするDNA
|
US5728553A
(en)
*
|
1992-09-23 |
1998-03-17 |
Delta Biotechnology Limited |
High purity albumin and method of producing
|
CA2150378C
(en)
*
|
1992-11-30 |
2007-10-30 |
Joel Moss |
Mammalian muscle nad:arginine adp-ribosyltransferase
|
FR2701263B1
(fr)
*
|
1993-02-09 |
1995-04-21 |
Elie Stefas |
Procédé d'obtention d'une composition aqueuse protéinique, composition correspondante, glycoprotéine contenue et son utilisation pour la stabilisation de l'albumine et la détection ou le dosage d'anticorps.
|
US5550114A
(en)
*
|
1993-04-02 |
1996-08-27 |
Thomas Jefferson University |
Epidermal growth factor inhibitor
|
AU695960B2
(en)
*
|
1993-04-07 |
1998-08-27 |
Georgetown University |
DNA encoding cobra C3, CVF1, and CVF2
|
US5714344A
(en)
*
|
1993-04-07 |
1998-02-03 |
Georgetown University |
Protease-derivatized CVF
|
US5762939A
(en)
*
|
1993-09-13 |
1998-06-09 |
Mg-Pmc, Llc |
Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
|
ES2370937T3
(es)
|
1993-09-13 |
2011-12-23 |
Protein Sciences Corporation |
Un método para producir vacunas antigripales polivalentes a base de hemaglutinina.
|
EP0722501B1
(en)
*
|
1993-10-05 |
2000-03-08 |
Miller Brewing Company |
Cloned pullulanase
|
US6020465A
(en)
*
|
1993-10-22 |
2000-02-01 |
University Of Connecticut |
Recombinant avian type i interferon
|
US5885567A
(en)
*
|
1993-10-22 |
1999-03-23 |
University Of Connecticut |
Treatment of infection in fowl by oral administration of avian interferon proteins
|
US5681931A
(en)
*
|
1995-03-15 |
1997-10-28 |
Becton, Dickinson And Company |
Human restrictin
|
US5883224A
(en)
*
|
1996-04-19 |
1999-03-16 |
Cytokine Sciences, Inc. |
Characterization of transfer factors and methods of use
|
US6111081A
(en)
*
|
1996-05-31 |
2000-08-29 |
Baylor College Of Medicine |
Lactoferrin variants and uses thereof
|
US5922320A
(en)
|
1996-06-14 |
1999-07-13 |
Georgetown University |
Recombinant proCVF
|
TW555765B
(en)
|
1996-07-09 |
2003-10-01 |
Amgen Inc |
Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
|
ES2207759T3
(es)
|
1996-12-06 |
2004-06-01 |
Amgen Inc. |
Terapia de combinacion que utiliza una proteina de union del factor de necrosis tumoral (tnf) en el tratamiento de enfermedades inducidas por el tnf.
|
FR2774988B1
(fr)
*
|
1998-02-16 |
2000-05-05 |
Commissariat Energie Atomique |
Procede de purification de la prpres a partir d'un echantillon biologique et ses applications
|
US6660843B1
(en)
*
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
US6433144B1
(en)
*
|
1999-01-12 |
2002-08-13 |
Viragen, Inc. |
Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods
|
GB9902000D0
(en)
*
|
1999-01-30 |
1999-03-17 |
Delta Biotechnology Ltd |
Process
|
US7087726B2
(en)
|
2001-02-22 |
2006-08-08 |
Genentech, Inc. |
Anti-interferon-α antibodies
|
CN103755800B
(zh)
|
2004-02-02 |
2016-02-24 |
Ambrx公司 |
经修饰的人类生长激素多肽与其用途
|
JP5401097B2
(ja)
|
2005-12-23 |
2014-01-29 |
ノボ・ノルデイスク・エー/エス |
分取逆相クロマトグラフィー(rpc)を使用するタンパク質精製
|
EP2132217A2
(en)
*
|
2007-02-26 |
2009-12-16 |
Alltech Associates Inc. |
Ultra-fast chromatography
|
RU2452491C1
(ru)
*
|
2010-11-10 |
2012-06-10 |
Александр Иванович Сотниченко |
Детоксикант пищеварительного тракта позвоночных
|